 Eszter Vladar
Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cilia | 19 | 2023 | 162 | 3.340 |
Why?
| | Epithelial Cells | 16 | 2023 | 958 | 2.610 |
Why?
| | Cell Polarity | 8 | 2020 | 131 | 2.180 |
Why?
| | Cystic Fibrosis | 10 | 2023 | 956 | 1.750 |
Why?
| | Wnt Signaling Pathway | 4 | 2023 | 147 | 1.580 |
Why?
| | Respiratory Mucosa | 8 | 2021 | 251 | 1.460 |
Why?
| | Trachea | 7 | 2020 | 235 | 1.270 |
Why?
| | Lung | 14 | 2023 | 3593 | 0.870 |
Why?
| | Vaping | 1 | 2023 | 45 | 0.820 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 72 | 0.790 |
Why?
| | Organogenesis | 2 | 2019 | 54 | 0.760 |
Why?
| | Centrioles | 5 | 2018 | 35 | 0.750 |
Why?
| | Rhinitis | 4 | 2023 | 128 | 0.680 |
Why?
| | Lung Diseases | 3 | 2022 | 703 | 0.670 |
Why?
| | Sinusitis | 4 | 2023 | 175 | 0.650 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2023 | 287 | 0.640 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2018 | 32 | 0.620 |
Why?
| | Asthma | 5 | 2023 | 2042 | 0.600 |
Why?
| | Wnt Proteins | 4 | 2020 | 135 | 0.600 |
Why?
| | Geminin | 1 | 2016 | 1 | 0.540 |
Why?
| | Movement | 1 | 2018 | 244 | 0.540 |
Why?
| | Mice | 18 | 2023 | 14935 | 0.540 |
Why?
| | Morphogenesis | 2 | 2017 | 161 | 0.530 |
Why?
| | Xenopus Proteins | 3 | 2013 | 56 | 0.520 |
Why?
| | beta Catenin | 3 | 2020 | 220 | 0.460 |
Why?
| | Signal Transduction | 8 | 2023 | 4524 | 0.440 |
Why?
| | Animals | 22 | 2023 | 31837 | 0.440 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2023 | 369 | 0.440 |
Why?
| | Olfaction Disorders | 3 | 2023 | 50 | 0.430 |
Why?
| | Microtubules | 1 | 2012 | 237 | 0.350 |
Why?
| | Receptors, Notch | 2 | 2023 | 85 | 0.350 |
Why?
| | Developmental Biology | 1 | 2009 | 18 | 0.340 |
Why?
| | Frizzled Receptors | 3 | 2020 | 22 | 0.330 |
Why?
| | Enterovirus Infections | 2 | 2023 | 160 | 0.310 |
Why?
| | Stem Cells | 2 | 2023 | 546 | 0.300 |
Why?
| | Melanocytes | 2 | 2020 | 55 | 0.290 |
Why?
| | Protein Transport | 2 | 2020 | 396 | 0.290 |
Why?
| | Humans | 37 | 2023 | 114935 | 0.290 |
Why?
| | Tumor Suppressor Proteins | 3 | 2020 | 282 | 0.280 |
Why?
| | Phosphoproteins | 1 | 2008 | 299 | 0.270 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 510 | 0.260 |
Why?
| | Smell | 2 | 2023 | 112 | 0.260 |
Why?
| | Epithelium | 2 | 2023 | 298 | 0.250 |
Why?
| | Cell Cycle Proteins | 2 | 2013 | 552 | 0.240 |
Why?
| | Mice, Transgenic | 5 | 2020 | 1953 | 0.240 |
Why?
| | Drosophila | 2 | 2020 | 133 | 0.240 |
Why?
| | Cytoskeleton | 2 | 2020 | 177 | 0.240 |
Why?
| | Cell Movement | 4 | 2020 | 867 | 0.230 |
Why?
| | Paranasal Sinuses | 2 | 2023 | 66 | 0.230 |
Why?
| | Cell Differentiation | 5 | 2021 | 1699 | 0.230 |
Why?
| | Wnt4 Protein | 1 | 2023 | 17 | 0.220 |
Why?
| | Primary Cell Culture | 2 | 2015 | 149 | 0.220 |
Why?
| | Membrane Proteins | 3 | 2019 | 1022 | 0.210 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 396 | 0.210 |
Why?
| | Picornaviridae Infections | 1 | 2023 | 30 | 0.210 |
Why?
| | Mutation | 6 | 2022 | 3353 | 0.210 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 73 | 0.210 |
Why?
| | Mucociliary Clearance | 2 | 2022 | 42 | 0.200 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 29 | 0.200 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 101 | 0.200 |
Why?
| | Aryldialkylphosphatase | 1 | 2022 | 18 | 0.200 |
Why?
| | Enoxaparin | 1 | 2022 | 52 | 0.190 |
Why?
| | Cysts | 1 | 2022 | 93 | 0.190 |
Why?
| | Interferons | 1 | 2022 | 150 | 0.190 |
Why?
| | Bacteriophages | 1 | 2022 | 75 | 0.180 |
Why?
| | Nicotine | 1 | 2023 | 266 | 0.180 |
Why?
| | Skin Neoplasms | 2 | 2020 | 762 | 0.180 |
Why?
| | Mycobacterium abscessus | 1 | 2022 | 98 | 0.180 |
Why?
| | Antiviral Agents | 2 | 2023 | 647 | 0.170 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2020 | 7 | 0.170 |
Why?
| | Nasal Mucosa | 1 | 2020 | 93 | 0.170 |
Why?
| | Acute Lung Injury | 1 | 2022 | 300 | 0.160 |
Why?
| | Chronic Disease | 5 | 2023 | 1593 | 0.160 |
Why?
| | Cyclin A1 | 1 | 2018 | 4 | 0.160 |
Why?
| | Particulate Matter | 1 | 2020 | 185 | 0.160 |
Why?
| | Cyclin E | 1 | 2018 | 21 | 0.160 |
Why?
| | Mammary Glands, Animal | 1 | 2019 | 116 | 0.160 |
Why?
| | Cadherins | 1 | 2019 | 176 | 0.150 |
Why?
| | Cell Nucleus | 2 | 2018 | 554 | 0.150 |
Why?
| | Cells, Cultured | 4 | 2020 | 3897 | 0.150 |
Why?
| | Mitosis | 1 | 2018 | 164 | 0.150 |
Why?
| | Purines | 1 | 2018 | 159 | 0.140 |
Why?
| | Pneumonia | 1 | 2022 | 568 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2015 | 135 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2022 | 336 | 0.140 |
Why?
| | Mice, Knockout | 1 | 2023 | 2586 | 0.140 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1523 | 0.140 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 55 | 0.140 |
Why?
| | Kidney Tubules | 1 | 2017 | 107 | 0.140 |
Why?
| | Nasal Polyps | 1 | 2017 | 49 | 0.140 |
Why?
| | Xenopus laevis | 3 | 2013 | 118 | 0.130 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 529 | 0.130 |
Why?
| | Single-Cell Analysis | 3 | 2022 | 189 | 0.130 |
Why?
| | Up-Regulation | 1 | 2018 | 812 | 0.130 |
Why?
| | Nevus, Pigmented | 1 | 2015 | 34 | 0.120 |
Why?
| | Tissue Fixation | 1 | 2015 | 27 | 0.120 |
Why?
| | Pericytes | 1 | 2014 | 24 | 0.120 |
Why?
| | Staining and Labeling | 1 | 2015 | 134 | 0.120 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4718 | 0.120 |
Why?
| | Body Patterning | 2 | 2019 | 126 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 137 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-myb | 1 | 2013 | 9 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1054 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 631 | 0.110 |
Why?
| | Smoking | 1 | 2020 | 1391 | 0.110 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 283 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 171 | 0.100 |
Why?
| | Microscopy, Electron | 1 | 2013 | 410 | 0.100 |
Why?
| | Female | 11 | 2023 | 59580 | 0.100 |
Why?
| | Embryo, Nonmammalian | 2 | 2012 | 173 | 0.100 |
Why?
| | Pregnancy | 1 | 2023 | 5527 | 0.100 |
Why?
| | Models, Biological | 2 | 2009 | 1630 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2015 | 696 | 0.090 |
Why?
| | Inflammation | 4 | 2022 | 2485 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2102 | 0.090 |
Why?
| | Aminophenols | 2 | 2022 | 112 | 0.090 |
Why?
| | Green Fluorescent Proteins | 2 | 2012 | 373 | 0.090 |
Why?
| | Obesity | 1 | 2022 | 2514 | 0.080 |
Why?
| | Adult | 8 | 2023 | 30608 | 0.080 |
Why?
| | Myoclonic Epilepsies, Progressive | 1 | 2008 | 1 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 390 | 0.080 |
Why?
| | Dishevelled Proteins | 1 | 2008 | 1 | 0.080 |
Why?
| | Rho Factor | 1 | 2008 | 2 | 0.080 |
Why?
| | Ataxia | 1 | 2008 | 35 | 0.080 |
Why?
| | Homozygote | 1 | 2008 | 188 | 0.080 |
Why?
| | Male | 11 | 2023 | 55663 | 0.070 |
Why?
| | Cell Division | 1 | 2009 | 759 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2007 | 7 | 0.070 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2007 | 49 | 0.070 |
Why?
| | Quality of Life | 3 | 2023 | 2359 | 0.070 |
Why?
| | Lentivirus | 1 | 2007 | 45 | 0.070 |
Why?
| | Crosses, Genetic | 1 | 2007 | 140 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2019 | 316 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 192 | 0.070 |
Why?
| | Transduction, Genetic | 1 | 2007 | 113 | 0.070 |
Why?
| | Mice, Inbred C3H | 1 | 2007 | 242 | 0.070 |
Why?
| | Machine Learning | 2 | 2020 | 318 | 0.070 |
Why?
| | Proteins | 1 | 2012 | 912 | 0.070 |
Why?
| | Models, Genetic | 1 | 2009 | 565 | 0.070 |
Why?
| | Actins | 1 | 2008 | 382 | 0.070 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 299 | 0.070 |
Why?
| | HEK293 Cells | 2 | 2022 | 591 | 0.060 |
Why?
| | Mutagens | 1 | 2004 | 17 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2004 | 58 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1737 | 0.060 |
Why?
| | Middle Aged | 6 | 2023 | 26806 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2023 | 62 | 0.050 |
Why?
| | Rhinovirus | 1 | 2023 | 41 | 0.050 |
Why?
| | Phosphofructokinase-2 | 1 | 2022 | 14 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2004 | 191 | 0.050 |
Why?
| | Quercetin | 1 | 2022 | 11 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2326 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2640 | 0.050 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 102 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 93 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 173 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 249 | 0.050 |
Why?
| | Bleomycin | 1 | 2022 | 228 | 0.050 |
Why?
| | Alleles | 2 | 2019 | 791 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 221 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 287 | 0.040 |
Why?
| | Prospective Studies | 2 | 2022 | 6218 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2012 | 1988 | 0.040 |
Why?
| | Mucin 5AC | 1 | 2020 | 48 | 0.040 |
Why?
| | Comparative Genomic Hybridization | 1 | 2020 | 28 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2022 | 246 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 99 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2020 | 109 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 250 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2012 | 2791 | 0.040 |
Why?
| | Child | 4 | 2020 | 18366 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 129 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2019 | 36 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 582 | 0.040 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 12 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 721 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 228 | 0.040 |
Why?
| | Mucin-5B | 1 | 2020 | 184 | 0.040 |
Why?
| | Enterovirus | 1 | 2019 | 72 | 0.040 |
Why?
| | Mucins | 1 | 2018 | 61 | 0.040 |
Why?
| | Embryonic Development | 1 | 2019 | 117 | 0.040 |
Why?
| | Air Pollution | 1 | 2020 | 170 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2012 | 353 | 0.040 |
Why?
| | Turbinates | 1 | 2017 | 12 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3549 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2019 | 295 | 0.040 |
Why?
| | Air Pollutants | 1 | 2020 | 244 | 0.040 |
Why?
| | Computer Systems | 1 | 2017 | 45 | 0.040 |
Why?
| | Child, Preschool | 2 | 2020 | 9086 | 0.030 |
Why?
| | Adolescent | 3 | 2020 | 17829 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1084 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 728 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1355 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1801 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2017 | 744 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2023 | 4427 | 0.030 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2014 | 24 | 0.030 |
Why?
| | Magnetics | 1 | 2014 | 39 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 10478 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 135 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2014 | 201 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 476 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1197 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1775 | 0.030 |
Why?
| | Mice, SCID | 1 | 2014 | 320 | 0.030 |
Why?
| | Ependyma | 1 | 2013 | 3 | 0.030 |
Why?
| | Xenopus | 1 | 2013 | 98 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2199 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1477 | 0.030 |
Why?
| | Algorithms | 1 | 2020 | 1474 | 0.030 |
Why?
| | Transcription Factors | 1 | 2020 | 1530 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 543 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2013 | 210 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2558 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 3418 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 1893 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 293 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2817 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 215 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2014 | 776 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1621 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 398 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 9105 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2770 | 0.020 |
Why?
| | Aged | 2 | 2020 | 19122 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 929 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2014 | 685 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 1843 | 0.020 |
Why?
| | Physical Chromosome Mapping | 1 | 2008 | 16 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2008 | 13 | 0.020 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2008 | 20 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6364 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 47 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2008 | 73 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2008 | 136 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 336 | 0.020 |
Why?
| | Genetic Markers | 1 | 2008 | 322 | 0.020 |
Why?
| | Pedigree | 1 | 2008 | 467 | 0.020 |
Why?
| | Skin | 1 | 2012 | 659 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 453 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 799 | 0.020 |
Why?
| | Kidney | 1 | 2012 | 1184 | 0.020 |
Why?
| | Nondisjunction, Genetic | 1 | 2004 | 3 | 0.010 |
Why?
| | Methyl Methanesulfonate | 1 | 2004 | 5 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 62 | 0.010 |
Why?
| | Meiosis | 1 | 2004 | 59 | 0.010 |
Why?
| | Mechlorethamine | 1 | 2004 | 64 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 176 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2004 | 490 | 0.010 |
Why?
| | DNA Repair | 1 | 2004 | 186 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2372 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2004 | 477 | 0.010 |
Why?
| | Base Sequence | 1 | 2004 | 2118 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1351 | 0.010 |
Why?
|
|
Vladar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|